NASDAQ

Stoke Therapeutics, Inc. (STOK)

♥ 588 Thanks from members

Live price chart, market sentiment, and community perspectives for Stoke Therapeutics, Inc. (NASDAQ: STOK).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: Genetic Medicine / BiotechnologyFounder: Adrian KrainerFounder: Lynne MaquatFounder: Rana SamadovLeadership: Edward M. Kaye (CEO)Leadership: Barry Greene (Chairman)Holder: Baker Bros. AdvisorsHolder: Fidelity ManagementHolder: Vanguard GroupSTK-001 (Dravet Syndrome)STK-002 (Autosomal Dominant Optic Atrophy)#STOK#Stoke Therapeutics#Genetic Medicine#RNA Therapeutics#Dravet Syndrome Treatment